Dialysis industry news

Stories from the dialysis comunity across the globe.



Kallikrein inhibitor ecallantide shows some benefit in ACEI-associated angioedema. PDF Print
University of Cincinnati: They wanted to see if Ecallantide, which has already safely treated acute attacks of hereditary angioedema, could help patients with ACEI angioedema—specifically, if it could make them eligible for discharge within four hours of treatment. After enrolling 50 patients in the study, they found that patients treated with Ecallantide were more likely to meet discharge sooner than those receiving antihistamines and steroids—31 percent of Ecallantide patients were eligible for discharge within four hours, as compared with 21 percent of patients receiving placebos. Additionally, patients experienced few side effects from the medication.

...

 
T cells targeting CS1 kill myeloma cells in animals. PDF Print
Ohio State University: The researchers modified a type of human immune cell – called T lymphocytes, or T cells – to target a molecule called CS1, which is found on more than 95 percent of myeloma cells, and to kill the cells. The researchers grew the modified cells in the lab to increase their numbers and then injected them into an animal model where they again killed human myeloma cells. The findings were published in the journal Clinical Cancer Research.

...

 
Aspirin retards wound healing PDF Print
EurekAlert: In addition to its known capacity to promote bleeding events, aspirin also inhibits wound healing. New research published in The Journal of Experimental Medicine now describes how aspirin acts on key skin cells called keratinocytes, delaying skin repair at wound sites. A better understanding of this process offers hope for the development of drugs to encourage wounds to heal.

...

 
American Society of Hypertension 2014 Annual Meeting starts in NYC. PDF Print
ASH: The program brochure can be found at this link: http://www.ash-us.org/documents/ASM/2014_ProRegBroc_r11_postOP_vert12-13_final.pdf

...

 
Health benefits of resveratrol via red wine called into question by study from Italy PDF Print
Huffpo: To examine the long-term impact of resveratrol, researchers looked to the longitudinal "Aging in the Chianti Region" study. They examined the compound's presence in urine samples from 783 healthy men and women, 65 years old or older, living in two Italian villages within the Chianti region.

...

 
<< Start < Prev 401 402 403 404 405 406 407 408 409 410 Next > End >>

Page 410 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.